Literature DB >> 19318376

Over-expression of calpastatin inhibits calpain activation and attenuates myocardial dysfunction during endotoxaemia.

Xiaoping Li1, Ying Li, Limei Shan, E Shen, Ruizhen Chen, Tianqing Peng.   

Abstract

AIMS: Lipopolysaccharide (LPS) induces cardiomyocyte caspase-3 activation and proinflammatory factors, in particular tumour necrosis factor-alpha (TNF-alpha) production, both of which contribute to myocardial dysfunction during sepsis. The present study was to investigate the roles of calpain/calpastatin system in cardiomyocyte caspase-3 activation, TNF-alpha expression, and myocardial dysfunction during LPS stimulation. METHODS AND
RESULTS: In cultured adult rat cardiomyocytes, LPS (1 microg/mL) induced calpain and caspase-3 activity, and up-regulated TNF-alpha expression. These effects of LPS were abrogated by over-expression of calpastatin, an endogenous calpain inhibitor, transfection of calpain-1 siRNA, or various pharmacological calpain inhibitors. Furthermore, blocking gp91(phox)-NADPH oxidase prevented calpain and caspase-3 activation and decreased TNF-alpha expression in LPS-stimulated cardiomyocytes. To investigate the role of calpastatin in endotoxaemia, transgenic mice with calpastatin over-expression (CAST-Tg) and wild-type mice were treated with LPS (4 mg/kg, i.p.) or saline in the presence of calpain inhibitor-III (10 mg/kg, i.p.) for 4 h, and their heart function was measured with a Langendorff system. Over-expression of calpastatin significantly attenuated myocardial dysfunction (P < 0.05). Consistently, calpain activity, caspase-3 activity, and TNF-alpha expression were also reduced in CAST-Tg and calpain inhibitor-III compared with wild-type and vehicle-treated hearts, respectively.
CONCLUSION: gp91(phox)-NADPH oxidase-mediated calpain-1 activation induces caspase-3 activation and TNF-alpha expression in cardiomyocytes during LPS stimulation. Over-expression of calpastatin inhibits calpain activation and improves myocardial function in endotoxaemia. The present study suggests that targeting calpain/calpastatin system may be a potential therapeutic intervention for septic hearts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318376     DOI: 10.1093/cvr/cvp100

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  38 in total

1.  Innate immune function of the adherens junction protein p120-catenin in endothelial response to endotoxin.

Authors:  Yan-Lei Wang; Yu Sun; Asrar B Malik; Sanyuan Hu; Albert B Reynolds; Richard D Minshall; Guochang Hu
Journal:  J Immunol       Date:  2011-01-28       Impact factor: 5.422

2.  Calpain-1 induces endoplasmic reticulum stress in promoting cardiomyocyte apoptosis following hypoxia/reoxygenation.

Authors:  Dong Zheng; Grace Wang; Shuai Li; Guo-Chang Fan; Tianqing Peng
Journal:  Biochim Biophys Acta       Date:  2015-02-04

Review 3.  Tear me down: role of calpain in the development of cardiac ventricular hypertrophy.

Authors:  Cam Patterson; Andrea L Portbury; Jonathan C Schisler; Monte S Willis
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

Review 4.  Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks.

Authors:  Simon S Wing; Stewart H Lecker; R Thomas Jagoe
Journal:  Crit Rev Clin Lab Sci       Date:  2011-06-24       Impact factor: 6.250

5.  Critical role of calpain in inflammation.

Authors:  Jingjing Ji; Lei Su; Zhifeng Liu
Journal:  Biomed Rep       Date:  2016-10-19

6.  Molecular Determinants of Calpain-dependent Cleavage of Junctophilin-2 Protein in Cardiomyocytes.

Authors:  Ang Guo; Duane Hall; Caimei Zhang; Tianqing Peng; Jordan D Miller; William Kutschke; Chad E Grueter; Frances L Johnson; Richard Z Lin; Long-Sheng Song
Journal:  J Biol Chem       Date:  2015-06-10       Impact factor: 5.157

7.  Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release.

Authors:  Lara Zafrani; Grigoris Gerotziafas; Colleen Byrnes; Xuzhen Hu; Joelle Perez; Charlène Lévi; Sandrine Placier; Emmanuel Letavernier; Asada Leelahavanichkul; Jean-philippe Haymann; Ismail Elalamy; Jeffrey L Miller; Robert A Star; Peter S T Yuen; Laurent Baud
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

Review 8.  Calpains and Coronary Vascular Disease.

Authors:  Brittany A Potz; Ashraf A Sabe; M Ruhul Abid; Frank W Sellke
Journal:  Circ J       Date:  2015-10-21       Impact factor: 2.993

9.  Role of Calpain in Pathogenesis of Human Disease Processes.

Authors:  Brittany A Potz; M Ruhul Abid; Frank W Sellke
Journal:  J Nat Sci       Date:  2016

10.  Endothelial ROS and Impaired Myocardial Oxygen Consumption in Sepsis-induced Cardiac Dysfunction.

Authors:  Brittany A Potz; Frank W Sellke; M Ruhul Abid
Journal:  J Intensive Crit Care       Date:  2016-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.